Patent

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (April 6 – April 12)

/ By / Copyright, Others, Patent, Trademark

Entering the second week of April announcing the faculty line up for the SpicyIP Summer School 2026! Two-part post on the purpose of copyright in academic work in the context of Sci-Hub litigation. Another post discussing whether trademark law can be used to reclaim what design law has deliberately released into the public domain? Case summaries and IP developments from the country and the globe and much more in this week’s SpicyIP Weekly Review. Anything we are missing out on? […]

SpicyIP Weekly Review (April 6 – April 12) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 30 – April 5)

/ By / Copyright, Design, Others, Patent, Trademark

Beginning April with a rundown of the major IP developments in 2025 on SpicyIP TV! Post on two recent Delhi High Court decisions in Geron and Hirotsu clarifying the boundaries of diagnostic methods exclusion. And another post on the UK Supreme Court’s decision in Emotional Perception AI Limited v Comptroller General of Patents marking a doctrinal shift in how subject-matter eligibility questions regarding computer programmes are evaluated. Case summaries and IP developments from the country and the globe and much

SpicyIP Weekly Review (March 30 – April 5) Read More »

Diagnosing the Diagnostic Exclusion: Have Geron and Hirotsu Resolved the Delhi High Court’s Troubles?

/ By / Patent

Section 3(i) of the Patents Act has long left the boundaries of diagnostic method exclusions uncertain, despite repeated judicial engagement. Two recent Delhi High Court decisions now offer the clearest articulation yet, bringing much-needed coherence to this evolving area of law. Shubham Thakare and Arpanjot Kaur explain these orders, highlighting how they not only clarify the legal position but also sharpen the policy tensions underlying the provision. Shubham is a third-year B.A., LL.B. (Hons.) student at the National Law School

Diagnosing the Diagnostic Exclusion: Have Geron and Hirotsu Resolved the Delhi High Court’s Troubles? Read More »

The UKSC’s “Any Hardware” Shortcut: Why Emotional Perception AI Raises More Questions Than It Answers — And Why India’s Framework Does Better

/ By / Patent

The UK Supreme Court’s decision in Emotional Perception AI Limited v Comptroller General of Patents marks a doctrinal shift in how subject-matter eligibility questions regarding computer programmes are evaluated. Irrespective of its impact, Pragati argues that the judgment is marked by a test that the Supreme Court itself chose not to apply and further contains three errors of reasoning. Pragati Upadhyay is a final-year student at the Faculty of Law, Banaras Hindu University, with a research focus on the intersection

The UKSC’s “Any Hardware” Shortcut: Why Emotional Perception AI Raises More Questions Than It Answers — And Why India’s Framework Does Better Read More »

Delay Enables Monopoly: How Inaction in the Opposition Proceedings at the Patent Office Undermines Access to Medicines

/ By / Patent

What happens when patent oppositions are filed, heard, but never decided? Highlighting the specific instances of prolonged delays at the Patent Office, Prathibha Sivasubramanian explains how administrative inaction is undermining a critical safeguard in patent law and how such delays can quietly enable monopolies and impact access to essential medicines. Prathibha Sivasubramanian is a Senior Researcher working with TWN. She has over a decade of experience in access to medicines, patents, and intellectual property. She has worked extensively on patent

Delay Enables Monopoly: How Inaction in the Opposition Proceedings at the Patent Office Undermines Access to Medicines Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 23 – March 29)

/ By / Copyright, Design, Others, Patent, Trademark

Almost at the end of March with a post on the wonder drug Semaglutide’s patent expiry and its impact in India. Post on the Calcutta HC’s judgment removing subject-matter objections to the registration of GUIs as a design under the Designs Act. Another post on the government-led blocking of 3100+ Telegram channels marking a significant shift in India’s intermediary liability regime and censorship architecture. Case summaries and IP developments from the country and the globe and much more in this

SpicyIP Weekly Review (March 23 – March 29) Read More »

[SpicyIP Tidbit] Patent’s Gone, War’s On: Inside Novo Nordisk’s Semaglutide Litigation Blitz

/ By / Patent, Trademark

Yesterday, Khushi and I wrote on the Semaglutide patent expiry and what it could mean for Indian generic companies and the general public. And while the market is seeing more affordable versions of the drug, a separate story is taking place in the Delhi High Court with Novo Nordisk filing a fresh set of trademark and patent infringement suits against generic companies.  The Ozempic Name Game: Novo Nordisk v. DRL Round 2 On Semaglutide injections, Novo Nordisk has filed a

[SpicyIP Tidbit] Patent’s Gone, War’s On: Inside Novo Nordisk’s Semaglutide Litigation Blitz Read More »

Wonder Drug, Generic Price: What Semaglutide’s Patent Expiry Should Really Mean for India

/ By / Patent

[This post is co-authored with Khushi Krishania. Khushi is a third-year B.Sc. LL.B. (Hons.) {Cybersecurity} student at the National Law Institute University, Bhopal, with a particular interest in the intersection of copyright and data protection law.] Christmas came early for Indian generic manufacturers as the Indian patent on Semaglutide, a potent GLP-1 receptor agonist, expired on March 20. The drug is commercially sold by Novo Nordisk as Ozempic and Wegovy and is used to manage type-2 diabetes and obesity. After

Wonder Drug, Generic Price: What Semaglutide’s Patent Expiry Should Really Mean for India Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 16 – March 22)

/ By / Copyright, Geographical Indication, Others, Patent, Trademark

(This week’s review is authored by Shubham Thakare. Shubham is currently an intern with SpicyIP. He is a third-year B.A., LL.B. (Hons.) student at the National Law School of India University, Bengaluru, with an interest in copyright and trademark law.) As we move further into March, this week’s review brings into focus questions around the limits of IP protection over identity, alongside a series of significant judicial developments across trademarks, patents, and copyright. From clarifying the misplaced claim of copyright

SpicyIP Weekly Review (March 16 – March 22) Read More »

TWN- IUCIPRS Workshop on Patent Opposition in Pharmaceutical Field (Apply by 31 March)

/ By / Courses & Workshops, Patent

Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are organising the 7th edition of their workshop titled ‘Patent Opposition in the Pharmaceutical Field’ from 28 May- 1 June, 2026. Last date to apply is 31 March, 2026. Read on below for their announcement. TWN- IUCIPRS Workshop on Patent Opposition in Pharmaceutical Field (Apply by 31 March) Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are collaboratively organising the seventh edition of the workshop titled ‘Patent Opposition in

TWN- IUCIPRS Workshop on Patent Opposition in Pharmaceutical Field (Apply by 31 March) Read More »

Scroll to Top